About Index Trending news
Analyze
Pricing
Amgen Inc.

Amgen Inc.

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.
I work here Suggest edits
More info

Elsewhere

Contributors to this profile

Companies in the same industry

AveXis AveXis InvivoSciences® Inc. InvivoSciences® Inc. ACEA Biosciences ACEA Biosciences Allergan plc Allergan plc Sophia Genetics Sophia Genetics Eli Lilly and Co Eli Lilly and Co Second Genome Second Genome Robert Gould Robert Gould ZetrOZ Inc ZetrOZ Inc Edison Pharma Edison Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 10

Portfolio

Portfolio tracker

Acquisitions 4

Apps 1
Add info

Investment profile

Target markets
Biotechnology

Activity

Past year's investments

- Amgen Ventures participated in 3 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $275,000,000 (averaging $91,666,667 per round).

Latest rounds

- WuXi NextCODE: Venture capital (Series B) ($240M)
- GNS Healthcare: Venture capital (Series C) ($6M)
- Science 37: Venture capital (Series C) ($29M)

Main Co-investors

- Domain Associates
- MPM Capital
- DAG Ventures

Science 37

Science 37

Health Care Information Technology
Total funding
$66.5M in 3 rounds from 12 investors
By Amgen Ventures
$29M Series C in Apr, 2017
Akili Interactive

Akili Interactive

Health Care +1
Total funding
$42.4M in 2 rounds from 5 investors
By Amgen Ventures
$11.9M Series B in Jul, 2016
GNS Healthcare

GNS Healthcare

Big Data Analytics +1
Total funding
$36.7M in 6 rounds from 13 investors
By Amgen Ventures
$6M Series C in Aug, 2017
WuXi NextCODE

WuXi NextCODE

Big Data +1
Total funding
$330M in 3 rounds from 9 investors
By Amgen Ventures
$240M Series B in Sep, 2017
miRagen Therapeutics

miRagen Therapeutics

Biotechnology +2
Total funding
$60.5M in 4 rounds from 18 investors
By Amgen Ventures
$8.5M Series C in Feb, 2015
Integrated Diagnostics

Integrated Diagnostics

Health Care +2
Total funding
$95.2M in 8 rounds from 18 investors
By Amgen Ventures
undisclosed deal in Jul, 2005
Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.

Biotechnology
Total funding
$52M in 2 rounds from 13 investors
By Amgen Ventures
$13.5M Series B in Jan, 2014
Alector

Alector

Biotechnology
Total funding
$29.5M in 1 rounds from 9 investors
By Amgen Ventures
$29.5M Series D in Jan, 2016
Tizona Therapeutics

Tizona Therapeutics

Therapeutics
Total funding
$43M in 1 rounds from 7 investors
By Amgen Ventures
$43M Series B in Mar, 2016

Want to see the complete list?
Go Pro!